Atypical symptoms of GORD in Belgium: Epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 2, 2006, Pages 203-208

  Louis, Edouard ^a   Jorissen, P ^b   Bastens, B ^b   D'Haens, G ^b   Schoofs, N ^b   Burette, A ^b   Christiaens, P ^b   Tack, J ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE

Author keywords

Atypical; ENT symptoms; Esomeprazole; Gord; Unexplained chest pain

Indexed keywords

ESOMEPRAZOLE; NEXIAM;

ADULT; AGED; ARTICLE; ASTHMA; BELGIUM; CONTROLLED STUDY; COUGHING; DATA ANALYSIS; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; ESOPHAGITIS; FEMALE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HALITOSIS; HEALTH SURVEY; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; OTORHINOLARYNGOLOGY; PATIENT CARE; PHYSICIAN; PRACTICE GUIDELINE; SORE THROAT; SYMPTOM; THORAX PAIN; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; BELGIUM; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMPS; TREATMENT OUTCOME;

EID: 33747589224     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. WIENBECK M., BARNERT J. Epidemiology of reflux disease and reflux oesophagitis. Scand. J. Gastroenterol., 1989, 24 (suppl. 56): 7-13.
2. LOUIS E., DELOOZE D., DEPREZ P., HIELE M., URBAIN D., PELCKMANS P., DEVIERE J., DELTENRE M. LOUIS E., DELOOZE D., DEPREZ P., HIELE M., URBAIN D., PELCKMANS P., DEVIERE J., DELTENRE M. Heartburn in Belgium: prevalence, impact on daily life and utilization of medical resources. Eur. J. Gastroenterol. Hepatol., 2002, 14: 279-284.
3. RICHTER J.E. Extraesophageal presentations of gastroesophageal reflux disease. Seminars in gastrointestinal disease, 1997, 8: 75-89.
4. FENNERTY M.B. Extraesophageal gastroesophageal reflux disease. Presentation and approach to treatment. Gastroenterology Clinics of North America, 1999, 28: 861-873.
5. LOUGHLIN C.J., KOUFMAN J.A. Paroxysmal laryngospasm secondary to gastroesophageal reflux. Laryngoscope, 1996, 106: 1502-5.
6. JANSSENS J., VANTRAPPEN G., GHILLEBERT G. 24-hour recording of oesophageal pressure and pH in patients with non-cardiac chest pain. Gastroenterology, 1986, 90: 1978-1984.
7. EL-SERAG H.B., SONNENBERG A. Comorbid occurrence of laryngeal or pulmonary disease with oesophagitis in United States military veterans. Gastroenterology, 1997, 113: 755-60.
8. LOCKE G.R., TALLEY N.J., FETT S.L., ZINSMEISTER A.R., MELTON L.J. Prevalence and clinical spectrum of gastro-oesophageal reflux: a population-based study in Olmsted county, Minnessota. Gastroenterology, 1997, 112: 1448-1456.
9. HEWSON E.G., SINCLAIR J.W., DALTON C.B., RICHTER J.E. Twenty-four-hour oesophageal pH monitoring: the most useful test for evaluating non-cardiac chest pain. Am. J. Med., 1991, 90: 576-583
10. KOUFMAN J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope, 1991, 101 (suppl. 53).
11. SONTAG S., SCHNELL T.G., MILLER T.Q., KHANDELWAL S., O'CONNELL S., CHEJFEC G., GREENLEE H., SEIDEL U.J., BRAND L. Prevalence of oesophagitis in asthmatics. Gut, 1992, 33: 872-6.
12. KAHRILAS P.J., QUIGLEY E.M.M. Clinical oesophageal pH recording: a technical review for practice guideline development. Gastroenterology, 1996, 110: 1982-1996.
13. SCHNATZ F.F., CASTELL J.A., CASTELL D.O. Pulmonary symptoms associated with gastro-oesophageal reflux: use of ambulatory pH monitoring to diagnosis and to direct therapy. Am. J. Gastroenterol., 1996, 91: 1715-1718.
14. BORZECKI A.M., PEDROSA M.C., PRASHKER M.J. Should noncardiac chest pain be treated empirically? A cost-effectiveness analysis. Arch. Intern. Med., 2000, 160: 844-52.
15. JASPERSEN D., WEBER R., HAMMAR C.H., DRAF W. Effect of omeprazole on the course of associated oesophagitis and laryngitis. J. Gastroenterol., 1996, 31: 765-7.
16. ORMSETH E.J., WONG R.K.H. Reflux laryngitis: pathophysiology, diagnosis and management. Am. J. Gastroenterol., 1999, 94: 2812-7.
17. EL-SERAG H.B., GILGER M., KUEBELER M., RABENECK L. Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology, 2001, 121: 1294-1299
18. SUAZO J., FACHA M.T., VALDOVINOS M.A. Case and control study of atypical manifestations in gastroesophageal reflux disease. Revista de Investigacion Clinica, 1998, 50: 317-322.
19. KOUFMAN J.A., BELAFSKY P., BACH K., DANIEL E., POSTMA G. Prevalence of oesophagitis in patients with pH-documented laryngopharyngeal reflux. Laryngoscope, 2002, 112: 1606-9.
20. OSSAKOW S.J., ELTA G., BOGDASARIAN R., COLTURI T., NOSTRANT T.T. Oesophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann. Otol. Rhinol. Laryngol., 1987, 96: 387-92.
21. WIENER G.J., COPPER J.B., WU W.C., KOUFMAN J.A., RICHTER J.E., CASTELL D.O. Is hoarseness an atypical manifestation of gastroesophageal reflux (GER)? An ambulatory 24-hour pH study. Gastroenterology, 1986, 90: A1691 (abstract).
22. STOEVELAAR H.J., MCDONNELL J., STALS H., SMETS L., BELGIAN EXPERT PANEL ON SYMPTOMATIC GORD. The appropriate management of symptomatic gastro-oesophageal reflux disease (GORD) in primary care: a systematic analysis of expert opinion. Acta Gastroenterol. Belg., 2003, 66: 265-270.
23. FASS R., FENNERTY M.B., OFMAN J.J. et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology, 1998, 115: 42-49.
24. WARING J.P., LACAYO L., HUNTER J. et al. Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease: diagnosis and response to therapy. Dig. Dis. Sci., 1995, 40: 1093-1097.
25. DE CAESTECKER J. Medical therapy for supraesophageal complications of gastroesophageal reflux. Am. J. Med., 1997, 103: 138S-143S.